PRP Therapy

PRP is derived from a small sample of your own blood (20 to 30 mL) that is centrifuged to concentrate the platelet fraction to 4 to 6 times the normal blood baseline. Platelets are densely packed with alpha granules containing over 30 bioactive growth factors — including Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-β (TGF-β), Vascular Endothelial Growth Factor (VEGF), Epidermal Growth Factor (EGF), and Insulin-like Growth Factor (IGF-1). When activated by calcium chloride and injected into or applied over skin, these growth factors trigger fibroblast proliferation, new collagen and elastin synthesis, angiogenesis (new blood vessel formation), and accelerated tissue regeneration — improving skin texture, hydration, tone, and laxity.

For facial skin rejuvenation, an initial induction protocol of 3 sessions spaced 4 to 6 weeks apart is standard. Clinical improvement in skin hydration and texture is visible from session 2, while collagen remodeling and elastin reorganization continue to mature over 3 to 6 months after the final induction session. Maintenance sessions every 6 to 12 months sustain and build upon initial results. The timeline is adjusted based on individual response, skin quality at baseline, and the specific condition being treated (fine lines, pigmentation, under-eye hollowing, acne scarring).

The Vampire Facial combines two modalities: first, microneedling (fractional needling with a medical-grade device such as Dermapen or SkinPen) creates thousands of micro-channels through the stratum corneum into the papillary dermis, triggering a wound-healing response and briefly opening direct channels through the skin barrier. The activated PRP is then applied topically immediately after microneedling and driven deep into the dermis via the micro-channels. This combined protocol enhances PRP absorption by 40 to 60% compared to topical application alone, amplifying collagen induction and producing superior improvements in skin texture, pore size, and superficial scarring.

Because PRP is derived entirely from your own blood (autologous), it carries no risk of allergic reaction, immune rejection, or disease transmission. Side effects are limited to minor injection-site redness, swelling, and occasional pinpoint bruising, resolving within 24 to 48 hours. Contraindications to PRP include: active platelet disorders or thrombocytopenia, anticoagulant therapy (warfarin, direct oral anticoagulants), active skin infection or open wounds in the treatment area, active cancer or ongoing chemotherapy, and uncontrolled immune conditions. A full medical history is reviewed before every session.

PRP and injectable treatments address different mechanisms of aging and are best viewed as complementary rather than competitive. PRP improves intrinsic skin quality — collagen density, hydration, texture, and cell turnover — but does not add measurable structural volume or relax muscles. Fillers restore lost volumetric contour (such as cheek projection or nasolabial fold depth) and Botox reduces muscular wrinkle formation. For comprehensive rejuvenation, PRP is an excellent biological adjunct that enhances the skin canvas; many patients achieve optimal results through a strategic combination of PRP, Botox, and hyaluronic acid skin boosters rather than relying on any single modality.

Clinical evidence most strongly supports facial PRP for: improving overall skin quality and radiance ("skin rejuvenation"); accelerating recovery and collagen induction after fractional laser or microneedling; reducing fine perioral and periorbital lines; improving the appearance of tear-trough hollowing (with subdermal injection technique); fading post-acne erythema; and improving superficial acne scarring. PRP shows moderate evidence for melasma in combination with microneedling. It is not appropriate as a primary treatment for deep static folds, severe skin laxity, or significant volume deficit.